Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity
Journal of Obesity · 2024
DOI: 10.1155/2024/3813621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obesity, 2024. Verfasst von Cinthia Vila Nova Santana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Pro-Opiomelanocortin, Forkhead Box Protein O3, Polymorphism, Single Nucleotide, Obesity, Morbid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Genetic variability significantly impacts metabolism, weight gain, and feeding behaviors, predisposing individuals to obesity. This study explored how variations in key genes related to obesity— FOXO3A (forkhead box O3), AMPK (protein kinase AMP‐activated), and POMC (proopiomelanocortin)—are associated with extreme obesity (EOB).
Methods
We conducted a case–control study with 251 EOB patients and 212 healthy controls with a body mass index (BMI) of less than 25 kg/m 2 . We genotyped 10 single nucleotide variants (SNVs) using TaqMan‐based assays.
Results
Four SNVs—rs1536057 in FOXO3A , rs103685 in AMPK , rs934778, and rs6545975 in POMC —were associated with an increased risk of EOB. The strongest association was observed with rs934778 ( POMC ), which had a maximum odds ratio (OR) of 5.26 (95% CI: 2.86–9.09). While these genetic variations are closely linked to EOB, they do not affect serum glucose, triglycerides, HDL, LDL, BMI, or waist circumference.
Conclusions
These findings indicate that factors beyond traditional metabolic pathways, potentially related to feeding behavior or hormonal regulation, may also link these genetic variations to obesity. Further research in a larger sample is essential to validate these findings and explore their potential to guide clinical interventions and public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil.
- Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade Ciências Médicas de Minas Gerais (FCMMG), Belo Horizonte, Brazil.
- INCT em Neurotecnologia Responsável (INCT-NeurotecR), Belo Horizonte, Brazil.
- Hospital Felício Rocho, Belo Horizonte, Brazil.
- Instituto de Biociências Botucatu, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Botucatu, Brazil.
ORCID-Profile: Cinthia Vila Nova Santana, Luiz Alexandre Viana Magno, Maria Angélica Rios, Valéria Cristina Sandrim, Luiz Armando De Marco, Débora Marques de Miranda, Marco Aurélio Romano-Silva
Zitieren
APA
Santana, C. V. N., Magno, L. A. V., Ramos, A. V., Rios, M. A., Sandrim, V. C., De Marco, L. A., de Miranda, D. M., & Romano-Silva, M. A. (2024). Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity. Journal of Obesity. https://doi.org/10.1155/2024/3813621
Vancouver
Santana CVN, Magno LAV, Ramos AV, Rios MA, Sandrim VC, De Marco LA, et al. Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity. Journal of Obesity. 2024. doi:10.1155/2024/3813621
BibTeX
@article{Santana2024,
author = {Santana, Cinthia Vila Nova and Magno, Luiz Alexandre Viana and Ramos, Adauto Versiani and Rios, Maria Angélica and Sandrim, Valéria Cristina and De Marco, Luiz Armando and de Miranda, Débora Marques and Romano-Silva, Marco Aurélio},
title = {Genetic Variations in AMPK , FOXO3A , and POMC Increase the Risk of Extreme Obesity},
journal = {Journal of Obesity},
year = {2024},
doi = {10.1155/2024/3813621}
}
EUVIMED